Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.933 | 45 | 1 | 1996 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 36 | 0 | 1999 | 2019 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.400 | None | 1.000 | 25 | 0 | 1996 | 2017 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.400 | None | 0.920 | 25 | 0 | 1991 | 2019 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.400 | None | 1.000 | 24 | 0 | 1996 | 2019 | ||||||||
|
PBX homeobox 1 | 0.534 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 18 | 0 | 1993 | 2019 | ||||||||
|
paired box 5 | 0.487 | 0.654 | 1.00 |
|
disease | 0.400 | None | 1.000 | 15 | 1 | 2006 | 2019 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
disease | 0.400 | None | 1.000 | 14 | 0 | 1991 | 2019 | |||||||||
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 11 | 1 | 2002 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 1.000 | 10 | 0 | 1991 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.400 | None | 1.000 | 10 | 0 | 1995 | 2019 | ||||||||
|
HLF transcription factor, PAR bZIP family member | 0.628 | 0.615 | 0.95 |
|
disease | 0.380 | None | 1.000 | 8 | 0 | 1994 | 2018 | ||||||||
|
transcription factor 3 | 0.476 | 0.846 | 2.6E-02 |
|
disease | 0.360 | None | 1.000 | 6 | 0 | 1991 | 2018 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 0.340 | None | 0.800 | 4 | 2 | 2000 | 2019 | ||||||||
|
AF4/FMR2 family member 1 | 0.659 | 0.423 | 0.71 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1994 | 2018 | ||||||||
|
forkhead box P1 | 0.460 | 0.808 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
disease | 0.100 | None | 0.975 | 81 | 0 | 1987 | 2020 | ||||||||
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
disease | 0.100 | None | 0.941 | 34 | 0 | 1987 | 2017 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 1986 | 2019 | ||||||||
|
cytokine receptor like factor 2 | 0.615 | 0.538 | 3.3E-07 |
|
disease | 0.100 | None | 0.941 | 17 | 1 | 2010 | 2019 | ||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2010 | 2019 | ||||||||
|
SPG7 matrix AAA peptidase subunit, paraplegin | 0.436 | 0.885 | 2.0E-36 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2010 | 2019 | ||||||||
|
nuclear receptor subfamily 1 group I member 3 | 0.448 | 0.846 | 3.5E-08 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2010 | 2019 | ||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2010 | 2019 | |||||||||
|
arrestin 3 | 0.460 | 0.846 | 0.10 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2010 | 2019 |